Blaze Bioscience publishes Phase-1 trial results of tozuleristide
  Author: Pankaj Singh

Exploratory studies with the Odyssey CLx (LI-COR Biosciences), FLUOBEAM®800 (Fluoptics), and SI...

Read More
Merck unveils results from Phase 2 trial of V114 vaccine in infants
  Author: Sunil Hebbalkar

V114 has secured a Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) to avert ...

Read More
TG Therapeutics unveils long-term data from ublituximab Phase 2 study
  Author: Paroma Bhattacharya

TG Therapeutics, a biopharmaceutical company focused on developing medicines for patients having B-cell mediated disea...

Read More
Merck KGaA, Darmstadt, Germany to acquire Intermolecular Inc.
  Author: Pankaj Singh

Reportedly, the Executive Board of Merck KGaA, Darmstadt, Germany and Intermolecular's Board of Direc...

Read More
Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
  Author: Saif Ali Bepari

Neurocrine Biosciences Inc., along with Voyager Therapeutics Inc., has reportedly announced the Phase 1 results from t...

Read More
3M to acquire medical device maker Acelity in a $6.7 billion deal
  Author: Paroma Bhattacharya

3M Co has reportedly announced it would acquire Acelity Inc, a privately-owned medical device maker, in a $6.7 billion...

Read More
PlantEXT Family Secret form JV to develop medical cannabis products
  Author: Saif Ali Bepari

PlantEXT Ltd. and BB1 Acquisition Corp have reportedly announced a joint venture agreement between PlantEXT and Family...

Read More
ContraFect presents positive data from Phase 2 trial of Exebacase
  Author: Saif Ali Bepari

The new data suggest the potential for exebacase to offer significant clinical assistance to patients with MRS...

Read More
Medbelle raises €6 Mn in Series A funding round for digital hospital
  Author: Pankaj Singh

Medtech startup Medbelle is reportedly building the first-ever digital hospital in the world, designed to supports pat...

Read More
Janssen unveils data from first phase-3 trial of single-tablet regimen
  Author: Pankaj Singh

The outcomes from the first prospective Phase 3 trial studying the rapid initiation of a single-tablet regimen...

Read More
Diameter Health raises USD 9.6 million in series A-1 funding round
  Author: Pankaj Singh

A new investor Optum Ventures, an independent venture fund of Optum, led the investment round ...

Read More
Amazon brings Alexa into healthcare with access to medical information
  Author: Pankaj Singh

Amazon has reportedly been making moves in healthcare sector and after signing an agreement with health providers unde...

Read More
Sun Pharma introduces an innovative chemotherapy product in the U.S
  Author: Pankaj Singh

The chemotherapy product, INFUGEM™, would be the nation’s first & only cancer drug that...

Read More
Trovagene’s Phase-2 trial shows resistance to anti-androgen therapy
  Author: Pankaj Singh

The patients, who showed an early response (at C1D8) with reduction in PSA levels, were tested positive for AR...

Read More
Algernon declares reduction of key fibrosis marker in a NASH study
  Author: Pankaj Singh

The company’s conducted biochemical analysis depicted that neither NP-135 or Cenicriviroc (CVC) showed a...

Read More
Netmeds acquires health tech start-up KiViHealth for $10 million
  Author: Pankaj Singh

The acquisition will help Netmeds to increase its market value against rivals like 1mg, mChemist, Pharmea...

Read More
BeatO raises INR 11-75 Crore in pre-Series A round of funding
  Author: Pankaj Singh

Apart from Orios Venture Partners, BeatO’s existing investors, Leo Capital & Blume Ventures a...

Read More
Roche’s Tecentriq immunotherapy for SCLC treatment approved by USDFA
  Author: Paroma Bhattacharya

The US FDA (Food & Drug Administration) has reportedly granted approval for Swiss drug-maker Roche Holding’s...

Read More
PhaseBios Phase 1 PB2452 clinical trial results published in the NEJM
  Author: Pankaj Singh

PhaseBio Biopharmaceuticals Inc., a U.S.-based clinical-stage biopharmaceutical company, has reportedly announced that...

Read More
HealthTrackRx™ forms JV with Marshall Health & Mountain Health Network
  Author: Pankaj Singh

The newly formed organization will focus on preventing an opioid epidemic in West Virginia and its s...

Read More
Biocartis inks deal with Bristol-Myers Squibb for IdyllaTM MSI testing
  Author: Paroma Bhattacharya

Biocartis Group, a molecular diagnostics company based in Belgium, has reportedly signed a collaboration deal with the...

Read More
EARS unveils AM-111 Phase 3 trial outcomes in a peer-reviewed article
  Author: Paroma Bhattacharya

Auris Medical Holding AG (EARS), a Switzerland-headquartered pharmaceutical company, has reportedly announced the publ...

Read More
Philips puts forth a buyout offer for Carestream’s HCIS business
  Author: Paroma Bhattacharya

Royal Philips, the Netherlands-based healthcare technology company, has reportedly entered into an agreement with Care...

Read More
Invicro & icometrix to offer comprehensive imaging core lab services
  Author: Pankaj Singh

A Konica Minolta company Invicro LLC has reportedly entered into a partnership with icometrix to seamlessly offer the ...

Read More
Dream Incubator leads health-tech firm NIRAMAI’s Series A funding
  Author: Ojaswita Kutepatil

NIRAMAI Health Analytix Pvt. Ltd., the Bengaluru-based breast cancer screening start-up, has reportedly raised around ...

Read More
UCSF scientists make stem cells that are invisible to immune system
  Author: Pankaj Singh

The feat is being touted as a breakthrough in biological engineering that prevented rejection of stem c...

Read More
Drug combination could set norms for advanced kidney cancer treatment
  Author: Paroma Bhattacharya

Reporting the results from a phase 3 clinical trial, an investigator from Dana-Farber Cancer Institute revealed that t...

Read More
IBM Watson collaborates with Broad Institute to explore genomics data
  Author: Paroma Bhattacharya

The initiative is expected enhance understanding of intrinsic possibility that individuals have for any specif...

Read More
MDISS expands cybersecurity standards to connected medical systems
  Author: Saif Ali Bepari

A nonprofit patient safety and public health organization, Medical Device Innovation, Safety, and Security Consortium ...

Read More
Orchard Therapeutics to present clinical data for OTL-101 & OTL-102
  Author: Saipriya Iyer

Biopharma major Orchard Therapeutics has reportedly made it to the front page for having announced details of oral and...

Read More
Ligand Pharmaceuticals confirms $3M investment in Dianomi Therapeutics
  Author: Saif Ali Bepari

Biopharmaceutical firm Dianomi Therapeutics, Inc., which is focused on the optimization of therapeutic profile of biol...

Read More
Hitachi Chemical to buy apceth Biopharma to expand its Europe presence
  Author: Saif Ali Bepari

The combined strength of the companies will enable clients to supply innovative and premium quality gene thera...

Read More
Lucence declares the opening of molecular diagnostics lab in Singapore
  Author: Paroma Bhattacharya

Lucence Diagnostics has reportedly made it to the headlines for having announced the opening of its new headquarters &...

Read More
Rutgers & Horizon plan to commercialize CRISPR base editing technology
  Author: Saipriya Iyer

Horizon has also agreed to fund further research in base editing at the Rutgers University. ...

Read More
NHS aims to roll out app therapy for children with mild depression
  Author: Ojaswita Kutepatil

The National Health Service reportedly aims to help children with mild depression through apps on their smartphones, p...

Read More
Telix Group inks deal with ININ to boost prostate imaging technology
  Author: Pankaj Singh

Telix Pharmaceuticals Limited, through its wholly-owned subsidiary Advanced Nuclear Medicine Ingredients SA (ANMI), ha...

Read More
MGC Pharmaceuticals gets approval for its cannabis dementia drug trial
  Author: Saif Ali Bepari

The company’s medical cannabis product, CogniCann, was granted approval to carry out the Phase II...

Read More
Anteo Diagnostics & Sona Nanotech team up to improve lateral flow tests
  Author: Pankaj Singh

* The collaboration aims to help accelerate the development & enhance lateral flow immunoassays’ performance...

Read More
Johnson & Johnson increases US prices on two-dozen prescription drugs
  Author: Pankaj Singh

* The company becomes the latest in a list of several other companies to increase the US prices on its drugs. ...

Read More
Pfizer to cease operation at two plants in Maharashtra & Tamil Nadu
  Author: Ojaswita Kutepatil

In what may seem to be a response against failing product demand, the U.S. drug manufacturer Pfizer announced that it ...

Read More
Zydus Cadila granted approval from US FDA to market antipsychotic drug
  Author: Pankaj Singh

Indian pharmaceutical firm Zydus Cadila has recently announced that the company has received final approval from the h...

Read More
Sanofi to pay $462m to Regeneron in a revised immuno-oncology deal
  Author: Pankaj Singh

The Paris-based multinational pharmaceutical firm, Sanofi S.A., would pay approximately $462 million to Regeneron, a N...

Read More
Samsung Bioepis-3SBio deal to aid China biosimilar business expansion
  Author: Saif Ali Bepari

In a recent turn of events, Samsung Bioepis Co. has reportedly announced the expansion of its rapidly growing biosimil...

Read More
Otsuka-Click alliance on digital therapeutics to help MDD patients
  Author: Saipriya Iyer

Otsuka America, Inc., and Click Therapeutics, Inc., have reportedly announced that they have signed an agreement to de...

Read More
Roche’s debut immunotherapy may gain approval post positive trials
  Author: Pankaj Singh

The Swiss drugmaker Roche on Monday revealed that the trials of their immunotherapy mixture, consisting of Tecentriq c...

Read More
AstraZeneca gets import & marketing approval for Durvalumab in India
  Author: Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from...

Read More
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
  Author: Dhananjay Punekar

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the f...

Read More
Novo Nordisk inks pact with Kallyope to tackle obesity & diabetes
  Author: Dhananjay Punekar

Kallyope Inc., a platform biotech company, and Novo Nordisk A/S, a Denmark based healthcare firm, have declared that t...

Read More
FDA grants supplemental ANDA approval for Glenmark’s Monroe unit
  Author: Dhananjay Punekar

Glenmark Pharmaceuticals, a pharma firm based in Mumbai, has received a green signal from U.S. FDA for its drug manufa...

Read More
Babylon teams with Bupa for offering AI tech to corporate customers
  Author: Dhananjay Punekar

Digital healthcare service provider Babylon Health has decided to join hands with Bupa, an international healthcare gr...

Read More
St. Louis based CQS signs LOI to purchase Remote Dosimetry Services
  Author: Dhananjay Punekar

Crux Quality Solutions LLC, renowned for the development of radiation oncology software products and services, has rep...

Read More
Mercy to invest USD 74 million at St. Anthony’s Medical Center
  Author: Dhananjay Punekar

Mercy, one of the largest Catholic health systems in the United States, will be constructing a 70,000-sq. foot standal...

Read More
Stryker proposes a takeover bid for Boston Scientific Corporation
  Author: Dhananjay Punekar

Stryker Corporation, a Fortune 500 medical tech firm, has reportedly announced that it plans to acquire Boston Scienti...

Read More
KKR nears deal to buy Envision Healthcare for USD 5.5 billion
  Author: Dhananjay Punekar

KKR & Co. L.P., a global investment firm, is reportedly on the verge of signing a purchase deal with Envision Heal...

Read More
Roche showcases new solutions for automated molecular testing
  Author: Ojaswita Kutepatil

The Swiss multinational Roche in its recent announcement has unveiled that it will be featuring its new test options t...

Read More
Royal Philips & SAM set up Advanced Medicine Imaging unit in Biopolis
  Author: Dhananjay Punekar

Royal Philips & Singapore Institute of Advanced Medicine Holdings (SAM) have inaugurated the USD 100 million Advan...

Read More
Mylan’s stocks surge post FDA’s approval of its biosimilar Fulphila
  Author: Dhananjay Punekar

The U.S. FDA has reportedly approved Neulasta’s biosimilar manufactured by Mylan N.V., a U.S. based generic &...

Read More
Amazon to spin up a secretive lab focused on cancer research
  Author: Ojaswita Kutepatil

Following its entry into the healthcare realm, the e-commerce behemoth Amazon has been recently found leading a secret...

Read More
HCA & CHS close major deals, bolster M&A trends in healthcare industry
  Author: Paroma Bhattacharya

HCA Healthcare, one of the leaders of hospital networks in Texas, reportedly stated that the executives of the busines...

Read More
Merck & Premier Inc. join hands to reduce C. diff recurrence
  Author: Dhananjay Punekar

Merck & Co., a U.S. based pharmaceutical giant, and Premier Inc., have reportedly extended their partnership on pr...

Read More
Minnesota sues Insys Therapeutics for illegally marketing opioid drug
  Author: Dhananjay Punekar

Minnesota has filed a litigation against Insys Therapeutics Inc., a U.S. based specialty pharma firm, for having illeg...

Read More
WellCare strikes 2.5-bn-dollar deal to buy MeridianHealth & MeridianRx
  Author: Dhananjay Punekar

With an aim to augment its Medicaid as well as Medicare services, WellCare Health Plans Inc. has decided to acquire th...

Read More
Alibaba to inject online pharmacy business into listed healthcare unit
  Author: Paroma Bhattacharya

Alibaba Group Holding Ltd, the Chinese e-commerce giant will be injecting some of its online pharmacy business to Alib...

Read More
Smiths Group plans £6 bn healthcare merger with ICU Medical
  Author: Ojaswita Kutepatil

British engineering business firm Smiths Group has reportedly opened talks with the U.S.-based ICU Medical Inc., over ...

Read More
Sanofi chooses Swansea as UKs pioneer Diabetes Centre of Excellence
  Author: Dhananjay Punekar

Sanofi S.A., a French pharma company, has joined hands with the UK-based Swansea University Medical School, opting for t...

Read More
Merck & WUSTL tie up to study gut bacteria with the help of CRISPR
  Author: Satarupa De

Globally acclaimed genome editing leader, Merck has scarcely announced its strategic collaboration with the Washington...

Read More
AstraZeneca & Emulate to bring advanced organ-on-chip tech in labs
  Author: Dhananjay Punekar

AstraZeneca Plc, a biopharma firm headquartered in the UK, has entered into a collaboration with Emulate Inc. to inclu...

Read More
FDA’s approval of Aimovig offers a ray of hope for migraine patients
  Author: Dhananjay Punekar

In what may seem to be breakthrough in the healthcare space, the U.S. FDA has scarcely approved Aimovig, a drug develo...

Read More
WHO publishes a catalogue of tests to prioritize disease diagnosis
  Author: Dhananjay Punekar

In what may seem to be quite a strategic move toward the improvisation of healthcare services across the globe, the Wo...

Read More
Medigene extends cancer immunotherapy alliance with bluebird bio
  Author: Dhananjay Punekar

Medigene AG, a Germany-based biotech firm, and bluebird bio Inc., have reportedly decided to extend their collaboratio...

Read More
Oncimmune makes EarlyCDT-Liver Test commercially available in the U.S.
  Author: Ojaswita Kutepatil

Leading early cancer diagnostics company, Oncimmune Holdings PLC, has recently announced that it has launched a liver ...

Read More
Genentech-Lodo sign agreement for soil-based drug discovery
  Author: Paroma Bhattacharya

Genentech, a Roche subsidiary, has reportedly signed a deal with Lodo Therapeutics for around $1 billion to employ the...

Read More
Global healthcare major Lilly to acquire ARMO BioSciences for $1.6b
  Author: Ojaswita Kutepatil

Renowned drugmaker Eli Lilly & Co., has recently announced a definitive agreement to acquire cancer immunotherapy ...

Read More
Takeda to buy London-listed drugmaker Shire for over GBP 45 billion
  Author: Ojaswita Kutepatil

Japan’s pharmaceutical industry major Takeda in its recent announcement has unveiled that it will be acquiring i...

Read More
GP Strategies buys out IC Axon to deliver training to pharma customers
  Author: Paroma Bhattacharya

GP Strategies Corporation, the international performance improvement solutions provider, has scarcely declared that it...

Read More